
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. (MAZE)
WebsitePrice
Market cap
Next catalystExpected 1H 2027MZE782 — planned CKD proof-of-concept trial · Trial initiationCompany release ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Partner / License out
PreINDP1P2P3FilingApproved